Detalhe da pesquisa
1.
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Blood
; 139(9): 1340-1358, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788382
2.
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Blood
; 134(5): 432-444, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151986
3.
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Blood
; 122(15): 2539-49, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23886836
4.
Recombination activation gene-2-deficient blastocyst complementation analysis reveals an essential role for nuclear factor I-A transcription factor in T-cell activation.
Int Immunol
; 23(6): 385-90, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21602176
5.
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.
Br J Haematol
; 153(5): 623-33, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21470196
6.
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Blood Adv
; 5(16): 3152-3162, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424320
7.
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
Blood Adv
; 3(8): 1255-1266, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987970
8.
ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo.
Exp Hematol
; 43(9): 770-4.e2, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937048
9.
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
Blood
; 111(1): 275-84, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17761520
10.
IFN-gamma-mediated inhibition of antigen receptor-induced B cell proliferation and CREB-1 binding activity requires STAT-1 transcription factor.
Eur J Immunol
; 33(4): 907-12, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12672056
11.
Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells.
Cell Immunol
; 225(1): 42-52, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14643303